Skip to content

Cannabis: all studies

Page 88 of 294: studies 871 to 880 of 2,937, newest first. Back to the cannabis overview

Research

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users

Addiction Biology December 22, 2019 Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al. 58 citations

Cannabis is the most commonly used illicit drug in the world. However, because of a changing legal landscape and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly cannabis impairment. Importantly, a growing body of evidence suggests that regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug....

DOI: 10.1111/adb.12870 (opens in new tab) Cannabidiol Context archaeology Dronabinol Effects of cannabis +4

Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016

Psychological Medicine December 16, 2019 C. Hjorthøj, Maria Larsen, M. Starzer et al.

Abstract Background Worldwide, cannabis is the most used illegal substance, and the use of cannabis has increased over the years. An increase in the level of tetrahydrocannabinol (THC) in cannabis has also been seen. It is currently unclear whether this has led to an increase in the incidence of cannabis-induced psychosis. We aimed to investigate (1) the development of incidence of...

Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity.

European Neuropsychopharmacology December 1, 2019 Natasha L. Mason, Eef L. Theunissen, Nadia R. P. W. Hutten et al.

Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Rodent studies suggest that Δ9-tetrahydrocannabinol (THC) activates dopaminergic neurons in the limbic system, subsequently enhancing dopamine, which is implicated in the rewarding...

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans

Translational Psychiatry November 18, 2019 Zhongshan Cheng, Chureerat Phokaew, Yi-Ling Chou et al. 4 citations

Abstract Cannabis, the most widely used illicit drug, can induce hallucinations. Our understanding of the biology of cannabis-induced hallucinations (Ca-HL) is limited. We used the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) to identify cannabis-induced hallucinations (Ca-HL) among long-term cannabis users (used cannabis ≥1 year and ≥100 times). A genome-wide...

DOI: 10.1038/s41398-019-0639-7 (opens in new tab) Full text (opens in new tab) Cannabis Genome-wide association study Meta-analysis Single-nucleotide polymorphism +3

Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task.

Addiction Biology November 2019 Christina S Meade, Ryan P Bell, Sheri L Towe et al.

Marijuana use, which is disproportionately prevalent among human immunodeficiency virus (HIV)-infected persons, can alter activity in fronto-parietal regions during cognitively demanding tasks. While HIV is also associated with altered neural activation, it is not known how marijuana may further affect brain function in this population. Our study examined the independent and additive effects of...

Chronic nicotine exposure attenuates the effects of Δ9 -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats.

Brain and Behavior November 2019 Laurie A Manwell, Tanya Miladinovic, Elana Raaphorst et al.

Anxiogenic and anxiolytic effects of cannabinoids are mediated by different mechanisms, including neural signaling via cannabinoid receptors (CBRs) and nicotinic cholinergic receptors (nAChRs). This study examined the effects of prior nicotine (the psychoactive component in tobacco) exposure on behavioral sensitivity to delta-9-tetrahydrocannabinol (THC; the psychoactive component of cannabis)...

DOI: 10.1002/brb3.1375 (opens in new tab) Full text (opens in new tab) Anxiety-related behavior Cross-sensitization Delta-9-tetrahydrocannabinol Drug abuse +2

How Cannabis Alters Sexual Experience: A Survey of Men and Women.

The Journal of Sexual Medicine November 1, 2019 E. Wiebe, Alanna Just

INTRODUCTION Cannabis is reported to enhance sexual function; yet, previous studies have shown that physiological and subjective indices of sexual arousal and motivation were associated with decreased availability of circulating endocannabinoid concentrations. AIM To explain this contradiction, we evaluated which aspects of sexual experience were enhanced or diminished by cannabis use. METHODS...

Cannabis and Psychosis Through the Lens of DSM-5

International Journal of Environmental Research and Public Health October 28, 2019 Nathan Pearson, James H. Berry 44 citations

Evidence for an association between cannabis and psychosis has been documented in literature in many forms including experimental studies, epidemiological data, and case series. The association has implications for psychotic outcomes ranging from mild to severe and occurring over minutes to years. Due to the huge variety of exposures and outcome measures reported, creating a coherent account of...

DOI: 10.3390/ijerph16214149 (opens in new tab) Cannabis Psychosis Schizophrenia object-oriented programming Context archaeology +2

Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure

Psychological Medicine October 16, 2019 Deepak C. D’Souza, Suhas Ganesh, Jose A Cortes-Briones et al.

Abstract Background The literature on psychosis-relevant outcomes in cannabis users does not adequately address the confounding effects of other substance use/misuse and psychiatric disorders. Methods We studied a unique population for whom cannabis use is central and necessary to their way of life. They are forbidden from using other substances, including tobacco and alcohol. Their use of...

How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.

Neuroscience & Biobehavioral Reviews September 30, 2019 A. Freeman, Kat Petrilli, Rachel Lees et al.

The recent liberalisation of cannabis regulation has increased public and scientific debate about its potential benefits and risks. A key focus has been the extent to which cannabidiol (CBD) might influence the acute effects of delta-9-tetrahydrocannabinol (THC), but this has never been reviewed systematically. In this systematic review of how CBD influences the acute effects of THC we...